Inborn errors of anti-viral interferon immunity in humans
- PMID: 22347990
- PMCID: PMC3280408
- DOI: 10.1016/j.coviro.2011.10.016
Inborn errors of anti-viral interferon immunity in humans
Abstract
The three types of interferon (IFNs) are essential for immunity against at least some viruses in the mouse model of experimental infections, type I IFNs displaying the broadest and strongest anti-viral activity. Consistently, human genetic studies have shown that type II IFN is largely redundant for immunity against viruses in the course of natural infections. The precise contributions of human type I and III IFNs remain undefined. However, various inborn errors of anti-viral IFN immunity have been described, which can result in either broad or narrow immunological and viral phenotypes. The broad disorders impair the response to (STAT1, TYK2) or the production of at least type I and type III IFNs following multiple stimuli (NEMO), resulting in multiple viral infections at various sites, including herpes simplex encephalitis (HSE). The narrow disorders impair exclusively (TLR3) or mostly (UNC-93B, TRIF, TRAF3) the TLR3-dependent induction of type I and III IFNs, leading to HSE in apparently otherwise healthy individuals. These recent discoveries highlight the importance of human type I and III IFNs in protective immunity against viruses, including the TLR3-IFN pathway in protection against HSE.
Figures

References
-
- Isaacs A, Lindenmann J. Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci. 1957;147(927):258–67. - PubMed
-
- Nagano Y, Kojima Y, Sawai Y. Immunity and interference in vaccinia; inhibition of skin infection by inactivated virus. C R Seances Soc Biol Fil. 1954;148(7–8):750–2. - PubMed
-
- Gresser I. The antitumor effects of interferon: a personal history. Biochimie. 2007;89(6–7):723–8. - PubMed
-
- Jouanguy E, Zhang SY, Chapgier A, Sancho-Shimizu V, Puel A, Picard C, Boisson-Dupuis S, Abel L, Casanova JL. Human primary immunodeficiencies of type I interferons. Biochimie. 2007;89(6–7):878–83. - PubMed
-
- Gresser I. Wherefore interferon? J Leukoc Biol. 1997;61(5):567–74. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous